Archive for the ‘Seeking Talent’ Category

National Resilience, Inc. is a first-of-its-kind manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption – the Acquisition of Two Premier Biologics Manufacturing Facilities: Boston and in Ontario, Canada


Reporter: Aviva Lev-Ari, PhD, RN

Resilience’s new facility, located at 500 Soldiers Field Rd., Boston, MA. (Photo: Business Wire) – The Genzyme-Sanofi Building


SAN DIEGO & BOSTON–(BUSINESS WIRE)–Resilience (National Resilience, Inc.), a new company building the world’s most advanced biopharmaceutical manufacturing ecosystem, announced it has acquired two premier commercial manufacturing facilities in North America, joining other facilities already in Resilience’s network to boost total capacity under management to more than 750,000 square feet.

“These locations will serve as hubs for the future of biopharma manufacturing, leading the way and shaping the future of Resilience.”

  • The acquired facilities include a 310,000-square-foot plant in Boston, MA, purchased from Sanofi; and in a separate transaction,
  • a 136,000-square-foot plant in Mississauga, Ontario, Canada.

Both facilities, which currently produce commercial, marketed products, will see significant investments as Resilience adds capacity and capabilities to produce new therapies at these locations. In addition, the company has offered employment to the existing plant staff and intends to add more jobs at each facility.

“We have big plans for these facilities including investing in new capacity, applying new manufacturing technologies, creating jobs and bringing in new customers,” said Rahul Singhvi, Sc.D, Chief Executive Officer of Resilience. “These locations will serve as hubs for the future of biopharma manufacturing, leading the way and shaping the future of Resilience.”

As part of its agreement with Sanofi, Resilience will continue to manufacture a marketed product at the Boston location. The facility plan includes a build out to facilitate multi-modality manufacturing and state-of-the-art quality laboratories to ensure safe, reliable supply to patients. The facility itself is certified ISO 14001 (Environmental management system), OSHAS 18001 (Health & safety management system) and ISO 50001 (Energy management system).​

This is currently the largest of several facilities in Resilience’s growing biologics and advanced therapeutics manufacturing network, with plans to acquire and develop other sites in the U.S. this year. The facility offers 24/7/365 production, multiple 2000L bioreactors capacity and multiple downstream processing trains, with investment in additional capabilities to come.

Our state-of-the-art flexible facility in Mississauga, Ontario, provides upstream, downstream and aseptic fill finish, and is designed to comply with cGMP. The plant has been inspected and approved by multiple regulatory bodies, and handles development and commercialized products.

About Resilience

Resilience (National Resilience, Inc.) is a first-of-its-kind manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption. Founded in 2020, the company is building a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale. Resilience offers the highest quality and regulatory capabilities, and flexible and adaptive facilities to serve partners of all sizes. By continuously advancing the science of biopharmaceutical manufacturing and development, Resilience frees partners to focus on the discoveries that improve patients’ lives.

For more information, visit www.Resilience.com.


Ryan Flinn
Head of Communications

Read Full Post »

Leaders in Pharmaceutical Business Intelligence (LPBI) Group is pleased to announce its sponsorship and invite you to attend the Dedicated Lifesciences/Healthcare Track at New York Venture Summit presented by youngStartup Ventures.

Reporter: Aviva Lev-Ari, PhD, RN




Official Logo of Leaders in Pharmaceutical Business Intelligence (LPBI) Group



Special discount.  Use discount code LPBIVIP and receive 10% off the “early bird” rates. Early bird rates expire at the end of May.


>> Call for Top Lifesciences/Healthcare Innovators to present to leading Investors (details below).


New York

Venture Summit

July 9th & 10th 2019 | Convene | New York City


Where Innovation Meets Capital





Come meet, interact and network with hundreds of VCs, Corporate VCs, angel investors, investment bankers and founders of venture backed, emerging and early stage companies on the Dedicated Lifesciences/Healthcare Track at the prestigious New York Venture Summit being held on July 9th & 10th 2019 at Convene, New York City.


Whether you’re a Lifesciences/Healthcare  startup seeking capital and exposure, or an investor seeking new deals, The New York Venture Summit presented by youngStartup Ventures – is the event of the year you won’t want to miss.


A highly productive venture conference, The New York Venture Summit is dedicated to showcasing VCs, Corporate VCs and angel investors committed to funding venture backed, emerging and early stage Lifesciences/Healthcare companies.


Partial list of VCs and Angels confirmed to speak and judge includes:

Jenny Abramson, Founder & Managing Partner, Rethink Impact | Nick Adams, Managing Partner & Co-Founder, Differential Ventures | Karine Agajanian, Senior Analyst, Anzu Partners | John Albright, Managing Partner, Relay Ventures | Andrew Aldrich, Principal, American Family Ventures | Liza Benson, Partner, Moderne Ventures | Lily Bernicker, Associate, Collaborative Fund | Laura Bock, Investor, QED Investors | Matt Brennan, Partner, General Catalyst Partners | Joel Brightfield, Principal, SixThirty | Ciara Burnham, Partner, QED Investors | Daniel Burstein, Managing Partner, Millennium Technology Value Partners | Don Burton, Founding & Managing Partner, LearnStart | Jason Cahill, Founder & Managing Director, McCune Capital | Alex Carusillo, Venture Associate, OCA Ventures | Benjamin Cukier, Founder, Centana Growth Partners | Ned Daoro, Senior Associate, Clocktower Technology Ventures | Soraya Darabi, General Partner, Trail Mix Ventures | Tyler Dean, Investor, Point72 Ventures | Parth Desai, Investor, Flare Capital Partners | Alan Du, Investor, Millennium Technology Value Partners | Tyler Durham, Principal, Schlumberger Ventures | Miriam Eaves, Venture Partner, BP Ventures | Kenny Estes, Co-Founder & Partner, West Loop Ventures | Dave Fan, Principal, Alumni Ventures Group | Michael Fanfant, Senior Associate, Runa Capital | Matt Fates, Founder & General Partner, Pulse Ventures | Sana Fathima, Investment Manager, Lockheed Martin Ventures | Lindsay Fitzgerald, Managing Director, American Express Ventures | Haley Fradkin, Investment Associate, Plum Alley Investments | Ben Freeberg, Senior Associate, Alpha Venture Partners | Kyle Fugere, Head of Ventures, dunnhumby Ventures | Anna Garcia, General Partner, Runway Venture Partners | Stephen Gilfus, Founder, Blackboard Inc. | Karim Gillani, General Partner, Luge Capital | Edward Greer, Corporate Technology Scout, Dow Ventures | John Gu, Investor, Spring Mountain Capital | Whitney Haring-Smith, Managing Partner, Anzu Partners | Will Hawkins, Senior Associate, Founder Collective | Martin Heidecker, Director, Investment Manager, Boehringer Ingelheim Venture Fund | Ann Hickey, Vice President, Town Hall Ventures | Kyle Howard-Johnson, Investor, Catalyst Investors | Vinay Iyengar, Investor, Bessemer Venture Partners | Deborah Jackson, Founder, Plum Alley Investments | Dhruv Jain, Investor, Bessemer Venture Partners | Del Johnson, Principal, Backstage Capital | Jay Karandikar, Venture Partner, New Crop Capital | Hana Khosla, Investor, Activant Capital | Avery Klemmer, Investor, FirstMark Capital | Jak Knowles, Vice President Venture Investments, Leaps by Bayer | Steve Konsek, Program Director, National Science Foundation | George Krautzel, Managing Partner, MissionOG | Ricky Lai, Senior Associate, Portag3 Ventures | Eddie Lee, Senior Associate, White Star Capital | Bion Ludwig, Partner, Savano Capital Partners | Coppelia Marincovic, Investment Manager, Solvay Ventures | Elizabeth McCluskey, Principal, Impact Engine | Shripal Meghani, Partner, Cleveland Clinic Ventures | Arpesh Mehta, Investment Director, DSM Venturing | Andrée-Lise Méthot, Founder & Managing Partner, Cycle Capital Management | Ed Michael, Co-founder and Managing Partner, LionBird Ventures | Sarah Millar, Associate, City Light Capital | Bá Minuzzi, General Partner, BABEL Ventures | Greg Neufeld, Partner, ValueStream Ventures | Jason Palmer, General Partner, New Markets Venture Partners | Matt Perlman, Principal, IA Capital Group | Victoria Pettibone, Managing Director, Astia Angels | Daniel Pianko, Partner, University Ventures | Adam Plotkin, Partner, ff Venture Capital | Jean-Noel Poirier, Managing Partner, Clean Energy Venture Group | Greg Pope, Principal, Anzu Partners | Alison Andrews Reyes, General Partner, 1843 Capital | Lisa Rhoads, Managing Director, Easton Capital | Douglas Roth, Managing Director, Connecticut Innovations | Boris Ryabov, Managing Partner, Bright Capital | Ernst Sack, Partner, Blue Bear Capital | Zak Schwarzman, Partner, MetaProp | Thomas Seo, Vice President, Citi Ventures | Connie Sheng, Founding Managing Partner, Nautilus Venture Partners | Jaidev Shergill, Managing Partner, Capital One Growth Partners | Zacary Sherman, Associate, Pereg Ventures | Nicole Shimer, Investment Associate, Insight Venture Partners | Raj Singh, Managing Partner, JetBlue Technology Ventures | Jean Sini, Angel Investor | Neil Swami, Principal, Catalyst Health Ventures | Erica Van, Associate, Charles River Ventures | Jamie M. Weston, Managing Director, Spring Mountain Capital | Anthony Xu, Partner, New Ground Ventures | Lisa Xu, Investor, FirstMark Capital | Wesley Yiu, Senior Associate, Triphammer Ventures | Chris Young, Partner, Revel Partners | Katherine Zamsky, Managing Partner, Carbon Ventures | Lu Zhang, Founder & Managing Partner, Fusion Fund | Greg Ziac, General Partner, NMT Capital | Chris Zock, Managing Director , Sandbox Insurtech Ventures and many more.


Special Offer:

Leaders in Pharmaceutical Business Intelligence Group has made special arrangement for our network to receive a special discount, currently 10% off the existing “early bird” savings. Early bird rates expire at the end of May.

This conference will be attended by the best people in the industry. Please register early to avoid disappointment. 


Register Today & Save Click here.   

(Use promo code “LPBIVIP”)


In addition to providing access to leading Investors, the conference will feature more than 100 pre-screened venture backed, emerging and early stage companies seeking capital, and hardcore networking. 




Get Noticed > Get Funded > Grow Faster


A select group of more than 100 Top Innovators from the Technology, Life Sciences/Healthcare, CleanTech and Fintech sectors will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Corporate Investors, Private Investors, Investment Bankers, and Strategic Partners.


Apply to Present / Nominate a company:

For more information or to be considered for one of the Top Innovator slots click here.


Seed Pitchfest:

If you are a seed stage company seeking angel funding of less than $1M (and have raised less than $300,000) click here to apply for our Seed stage track.


We look forward to seeing you there. 


Leaders in Pharmaceutical Business Intelligence (LPBI) Group


youngStartup Ventures

Read Full Post »

Independent Public Relations Professionals with extensive experience in the biotechnology/drug development sector – Please Contact Me

Reporter: Aviva Lev-Ari, PhD, RN

We are seeking an independent public relations professional with extensive experience in the biotechnology/drug development sector to assist on a freelance basis to

  • promote an on line resource in drug development and personalized medicine in the global oncology sector. 

Responsibilities include working with agencies such as PR Newswire to distribute press releases prepared by us in house, and managing our proprietary mailing list and our social media accounts. 

Please, provide a detailed resume with contact information to knowledgebase@newmedinc.com.


Read Full Post »

%d bloggers like this: